glp-1 mimetics GLP-1s & Beyond: Understanding Incretin Mimetic Opportunities Clinical Focus on GLP-1 Agonists

However, avoid excessive doses potentially interfering with necessary acute inflammation

This question is crucial for many women considering its use during this sensitive time

PMCID: PMC11078072

doi: 10.3389/fendo.2025.1570603 Received 03 February 2025 Accepted 29 April 2025 Published 21 May 2025 Volume 16 - 2025 Edited by Jared Rutter, The University of Utah, United States Reviewed by Steven Patterson, Glasgow Caledonian University, United Kingdom Elena Jimenez Marti, University of Valencia, Spain Nigel Irwin, Ulster University, United Kingdom Updates Copyright 2025 Koefoed-Hansen, Helsted, Kizilkaya, Lund, Rosenkilde and Gasbjerg

10.4077/cjp.2009.amh036 12 ChenM.JiangL.LiY.BaiG.ZhaoJ.ZhangM.et al (2017)

A review of the new GLP-1 receptor agonist/basal insulin fixed-ratio combination products